IL-8 is a key mediator of neuroinflammation in severe traumatic brain injuries
- PMID: 14753466
- DOI: 10.1007/978-3-7091-0651-8_74
IL-8 is a key mediator of neuroinflammation in severe traumatic brain injuries
Abstract
The subjects were 22 patients with severe head injury. The average age was 45 +/- 18.3 years. There were 13 survivors and 9 fatalities. Samples of peripheral blood and cerebrospinal fluid (CSF) were taken four times, at the time of admission and at 24, 72, and 168 hours later. IL-6: For the survivor group, peripheral blood levels were 181, 105, 37, and 26 pg/ml, respectively (median values). CSF levels were 5376, 3565, 328, and 764 pg/ml, respectively. For the fatality group, peripheral blood levels were 102, 176, 873, and 3059 pg/ml, respectively, whereas CSF levels were 15241, 97384, 548225, and 366500 pg/ml, respectively. IL-8: For the survivor group, peripheral blood levels were 36, 15, 15, and 15 pg/ml, respectively, whereas CSF levels were 23736, 4074, 355, and 1509 pg/ml, respectively. For the fatality group, peripheral blood levels were 21, 28, 43, and 77 pg/mL, respectively, whereas CSF levels were 29003, 8906, 5852, and 8220 pg/ml, respectively. IL-6 and IL-8 levels were significantly higher after 72 hours in the fatality group. The fact that CSF IL-8 was 1000 times that in the peripheral blood at the time of admission, and decreased thereafter, indicates that IL-8 is a key mediator of neuroinflammation.
Similar articles
-
Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production.J Cereb Blood Flow Metab. 1997 Mar;17(3):280-9. doi: 10.1097/00004647-199703000-00005. J Cereb Blood Flow Metab. 1997. PMID: 9119901
-
Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.Shock. 2004 Aug;22(2):102-7. doi: 10.1097/01.shk.0000131193.80038.f1. Shock. 2004. PMID: 15257081
-
Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury.Shock. 2001 Jun;15(6):421-6. doi: 10.1097/00024382-200115060-00002. Shock. 2001. PMID: 11386612
-
Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries.Shock. 1995 Nov;4(5):311-7. doi: 10.1097/00024382-199511000-00001. Shock. 1995. PMID: 8595516
-
IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.J Neuroimmunol. 1999 Nov 15;101(2):211-21. doi: 10.1016/s0165-5728(99)00148-4. J Neuroimmunol. 1999. PMID: 10580806
Cited by
-
Blood-Based Biomarkers for Neuroprognostication in Acute Brain Injury.Semin Neurol. 2023 Oct;43(5):689-698. doi: 10.1055/s-0043-1775764. Epub 2023 Sep 26. Semin Neurol. 2023. PMID: 37751855 Review.
-
Beneficial Effect of Immune-Enhanced Enteral Nutrition on Immune Function in Patients With Severe Neurological Diseases: A Single-Center Randomized Controlled Trial.Front Nutr. 2021 Aug 23;8:685422. doi: 10.3389/fnut.2021.685422. eCollection 2021. Front Nutr. 2021. PMID: 34497819 Free PMC article.
-
Innate Immune Functions of Astrocytes are Dependent Upon Tumor Necrosis Factor-Alpha.Sci Rep. 2020 Apr 27;10(1):7047. doi: 10.1038/s41598-020-63766-2. Sci Rep. 2020. PMID: 32341377 Free PMC article.
-
Systemic Inflammation Persists the First Year after Mild Traumatic Brain Injury: Results from the Prospective Trondheim Mild Traumatic Brain Injury Study.J Neurotrauma. 2020 Oct 1;37(19):2120-2130. doi: 10.1089/neu.2019.6963. Epub 2020 Jun 3. J Neurotrauma. 2020. PMID: 32326805 Free PMC article.
-
Pathological vascular and inflammatory biomarkers of acute- and chronic-phase traumatic brain injury.Concussion. 2017 Mar 17;2(1):CNC30. doi: 10.2217/cnc-2016-0022. eCollection 2017 Mar. Concussion. 2017. PMID: 30202571 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical